Shijun Zhang
Assistant Professor
●EDUCATION
Ph.D. in Pharmaceutical Sciences,
M.S. in Medicinal Chemistry,
B.S. in Pharmacy,
●PROFESSIONAL EXPERIENCE
2007-Present Assistant Professor, Department of Medicinal Chemistry,
School of Pharmacy,
2005-2007 Postdoctoral Associate, Department of Medicinal Chemistry,
2000-2004 Graduate Research Assistant,
●PUBLICATIONS
1. Li, Q.; Wu, J.; Zheng, H.; Liu, K.; Guo, T.L.; Liu, Y.; Eblen, S.T.; Grant, S.; Zhang, S. Discovery of 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine-2,4-dione as a dual inhibitor of the Raf/MEK/ERK and the PI3K/Akt signaling pathways. Bioorg. & Med. Chem. Lett. 2010, 20, 4526-4530.
2. Lenhart, J.A.; Ling, X.; Gandhi, R.; Guo, T.L.; Gerk, P.M.; Brunzell, D.H.; Zhang, S. "Clicked" bivalent ligands containing curcumin and cholesterol as multifunctional Abeta oligomerization inhibitors: Design, synthesis, and biological characterization. J. Med. Chem. 2010, 53, 6198-6209.
3. Liu, K.; Rao, W.; Parikh, H.; Li, Q.; Guo, T.L.; Grant, S.; Kellogg, G.E.; Zhang, S. 3,5-Disubstituted- thiazolidine-2,4-dione analogs as anticancer agents: Design, synthesis and biological characterization. Eur. J. Med. Chem. 2012, 47, 125-137.
4. Liu, K.; Guo, T.L.; Chojnacki, J.; Lee, H.G.; Wang, X.; Siedlak, S.L.; Rao, W.; Zhu, X.; Zhang, S. Bivalent ligand containing curcumin and cholesterol as a fluorescent probe for Aβ plaques in Alzheimer’s disease. ACS Chem. Neurosci. 2012, 3, 141-146.
5. Liu, K.; Gandhi, R.; Chen, J.; Zhang, S. Bivalent ligands targeting multiple pathological factors involved in Alzheimer’s disease. ACS Med. Chem. Lett. 2012, 3, 942-946.
6. Liu, K.; Chen, J.; Chojnacki, J.; Zhang,
of difluoroboron-derivatized curcumins from aldehyde and 2,4-pentanedione. Tetrahedron Lett. 2013, 54, 2070-2073.
7. Liu, K.; Guo, T.L.; Hait, N.; Parikh, H.; Wang, X.; Xu, W.; Kellogg, G.E.; Milstien, S.; Grant, S.; Spiegel, S.; Zhang, S. Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene-]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase 2 inhibitor and anticancer agent. PLoS One 2013, 8, e56471.
8. Liu, K.; Zhang, D.T.; Chojnacki, J.; Du, Y.; Fu, H.; Grant, S.; Zhang, S. Design and biological characterization of hybrid compounds of curcumin and thalidomide for multiple myeloma. Org. & Biomol. Chem. 2013, 11, 4757-4763. (Featured as the HOT Article)